Challenging the Credibility of Chemical Assessments: The EPA's Controversial Stance on IRIS
A program within the Environmental Protection Agency (EPA) known as IRIS has been responsible for assessing the toxicity of chemicals for many years. These assessments form the basis of numerous chemical regulations and environmental rules in the United States and globally. However, the Trump administration is now casting doubt on the credibility of over 500 chemical assessments conducted by IRIS, potentially weakening efforts to safeguard people from harmful chemicals at state and federal levels. This move could even impact established standards regarding the permissible levels of substances like arsenic in drinking water and lead in paint and soil.
In an internal memo obtained by ProPublica, David Fotouhi, the EPA's deputy administrator, criticized IRIS and instructed EPA offices and external entities to review the chemical assessments produced by the program. The memo also warned against using these assessments in future regulations and proposed adding disclaimer language to the IRIS website. This development has raised concerns that companies may exploit this skepticism to challenge regulations they oppose, undermining efforts to protect the public from chemical hazards.
Critics of IRIS, including industry representatives, have long argued that the program's toxicity assessments are overly cautious. Fotouhi's background as a lawyer representing companies accused of toxic pollution has fueled suspicions about the motives behind the memo. While the EPA maintains that the directive does not compromise environmental protections, environmental advocates fear that it could embolden polluting companies to contest regulations based on IRIS assessments.
Established in 1985, IRIS has been a vital resource for information on chemical toxicity, guiding regulatory decisions at various levels. The program's meticulous assessments have been instrumental in setting emission limits for industrial facilities, informing state regulations, and influencing environmental policies worldwide. However, the recent memo signals a shift away from IRIS as EPA offices are now tasked with conducting toxicity assessments, potentially undermining the program's longstanding role in safeguarding public health.
Despite past criticisms and calls for its elimination, IRIS has been recognized for its thorough and impartial evaluations of toxic chemicals. While the program has faced scrutiny from scientific bodies in the past, its assessments have been valued for their rigor and independence from industry influence. The recent memo represents a significant departure from the EPA's previous support for IRIS, raising concerns about the future of chemical regulation and public health protections.
The EPA's decision to question the validity of IRIS assessments has sparked controversy and drawn criticism from environmental advocates. By casting doubt on the program's findings and suggesting that they are overly cautious, the agency risks undermining decades of scientific research and regulatory efforts aimed at protecting people from harmful chemicals. This shift in approach could have far-reaching implications for public health and environmental safety, potentially benefiting industries at the expense of community well-being.